Millrace Asset Group’s Apollo Endosurgery, Inc. APEN Stock Holding History

Millrace Asset Group’s Portfolio APEN Stock Details APEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-99,035	Closed	-$710K	–	75
2018 Q3	$710K	Sell	99,035 -58,466	-37%	-$454K	0.55%	62
2018 Q2	$1.1M	Buy	+157,501	New	+$979K	0.84%	57

Other funds holding APEN

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millrace Asset Group's APEN Position: Q4 2018 in Review

Millrace Asset Group sold out of Apollo Endosurgery, Inc. (APEN) in Q4 2018, closing a stake of 99,035 shares — an estimated $710K sold.

Millrace Asset Group first reported a position in APEN in Q2 2018 and held it in 2 quarters. The position peaked at $1.1M in Q2 2018. 35 funds tracked by Wall St. Rank hold APEN as of Q4 2018.

Millrace Asset Group reported no remaining Apollo Endosurgery, Inc. position as of Q4 2018 after selling out during the quarter.
Millrace Asset Group sold 99,035 Apollo Endosurgery, Inc. shares in Q4 2018, an estimated $710K.
Millrace Asset Group first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 2 quarters.
Millrace Asset Group's Apollo Endosurgery, Inc. position peaked at $1.1M in Q2 2018.
35 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q4 2018.

Based on Millrace Asset Group's 13F filing for Q4 2018, filed 13 Feb 2019.